Atea Pharmaceuticals (AVIR) Stock Forecast
Ninghpa hpeh$5.18Updated 25 Sep 2026 19:59 UTC
Change+0.19%
AI forecast: AVIR
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Ninghtang 6 hpeh hta rai
Premium shi AI hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe 1 dai, 1 rai hte 1 hpa hpang hta a mung ai hpe shan ai.
Unlock Premium🔒 Ninghkang hpe hkum hkum hpe hta
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumNinghpaw hta mung
Atea Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the discovery of oral direct-acting antiviral drugs. Atea Pharmaceuticals serves patients, healthcare professionals, and the pharmaceutical and biotechnology industries worldwide.
